文献速递免疫规划传染病防控与疫情报告

丹麦2000-2014年全国性研究:肺炎球菌结合疫苗接种对抗生素使用和鼓膜置管插入的影响

A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014.
PubMed 文献 · Vaccine · 2017-09-18

该研究为基于人群的回顾性观察研究,比较丹麦2000-2014年抗生素处方和鼓膜置管插入(VTI)发生率趋势,期间2007年引入PCV7、2010年引入PCV13。结果显示疫苗接种后抗生素使用从接种前持续上升转为所有0-15岁儿童下降,2014年2.4 DDD/人年接近2000年2.3 DDD/人年;VTI在PCV13后下降,2014年35/1000人年略高于2000年31/1000人年。作者结论认为疫苗接种可能减少了丹麦肺炎球菌所致上呼吸道疾病的发生。

要点

  • PCV7和PCV13引入后,0-15岁儿童抗生素处方发生率从接种前持续上升转为下降。
  • 2014年抗生素使用为2.4 DDD/人年,与2000年2.3 DDD/人年几乎持平。
  • VTI发生率在PCV13后下降,2014年35/1000人年略高于2000年31/1000人年。

核心结论

  • 接种前抗生素使用和VTI的持续上升在PCV引入后部分逆转至接近2000年水平,表明儿童疫苗接种计划中肺炎球菌疫苗的实施可能减少了丹麦肺炎球菌所致上呼吸道疾病的发生。

研究设计与样本

  • 基于人群的回顾性观察研究,比较2000-2014年抗生素处方和鼓膜置管插入(VTI)发生率趋势,期间2007年引入PCV7、2010年引入PCV13。

主要发现

  • PCV7和PCV13引入与抗生素处方发生率变化相关:从接种前几乎稳定上升转为所有0-15岁儿童下降。
  • 2014年抗生素使用为2.4 DDD/人年,与2000年2.3 DDD/人年几乎相同。
  • 在接种率较高的小于5岁年龄组观察到类似模式。
  • VTI在PCV13引入后数年发生率下降,2014年为35/1000人年,略高于2000年的31/1000人年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Introduction of Pneumococcal Conjugated Vaccines (PCV) in national immunization programs have been successful in reducing the number of invasive and lower respiratory pneumococcal infections. The impact of the vaccines on upper respiratory infections caused by pneumococci is less clear although these account for most pneumococcal infections. In this study, we used likely proxies for respiratory infections in children, such as antibiotic use and ventilation tube insertions (VTI), to estimate the impact of the vaccine on a national level. The study was designed as a population-based retrospective observational study, comparing trends in the incidence rate of antibiotic prescriptions and VTIs in the period 2000-2014, where PCV7 was introduced in 2007 and PCV13 in 2010. The introduction of PCV7 and PCV13 correlated with changes in the incidence rate from an almost steady increase in prescription of antibiotics in the pre-PCV period to a decreasing incidence for all children age 0-15years. The 2.4 DDD per person year in 2014 was at almost the same level of antibiotic use as in 2000 at 2.3 DDD per person year. Similar patterns were observed in the mostly vaccinated age groups below 5years of age. For VTI we observed a decreasing incidence rate in the years following introduction of PCV13 ending with a slightly higher incidence at 35 per 1000 person years in 2014 compared to 31 in year 2000. We conclude that the steady increase in antibiotic use and VTI in the pre-PCV period have been partially reversed to near year 2000 levels after the introduction of PCV. This indicates that implementation of pneumococcal vaccines in the Childhood Vaccination Programme has likely reduced the incidence of upper respiratory diseases due to pneumococci in Denmark.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Howitz MF, Harboe ZB, Ingels H, et al. A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014. Vaccine. 2017. PMID: 28928078. doi:10.1016/j.vaccine.2017.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。